1.
Contact Dermatitis
; 50(6): 381-2, 2004 Jun.
Article
in English
| MEDLINE
| ID: mdl-15274737
ABSTRACT
Contact sensitization has been an accepted topical immunotherapy in the treatment of alopecia areata (1, 2). Whether the age of patients is a significant factor in the treatment results is a matter of controversy. In our study, we investigated the correlation between age of the patients and diphenylcyclopropen-one contact sensitization in vivo and in vitro (3, 4).